Jain Kishor S, Kathiravan M K, Somani Rahul S, Shishoo Chamanlal J
Sinhgad College of Pharmacy, S. No. 44/1, Vadgaon(Bk.), Sinhgad Road, Pune 411 041, India.
Bioorg Med Chem. 2007 Jul 15;15(14):4674-99. doi: 10.1016/j.bmc.2007.04.031. Epub 2007 Apr 25.
Coronary arterial diseases are responsible for more deaths than all other associated causes combined. Elevated serum cholesterol levels leading to atherosclerosis can cause coronary heart disease (CHD). Reduction in serum cholesterol levels reduces the risk for CHD, substantially. Medicinal chemists all around the world have been designing, synthesizing, and evaluating a variety of new bioactive molecules for lowering lipid levels. This review summarizes the disorders associated with elevation of lipids in blood and the current strategies to control them. The emphasis has been laid in particular on the new potential biological targets and the possible treatments as well as the current ongoing research status in the field of lipid lowering agents.
冠状动脉疾病导致的死亡人数比所有其他相关原因导致的死亡人数总和还要多。血清胆固醇水平升高导致动脉粥样硬化,可引发冠心病(CHD)。降低血清胆固醇水平可大幅降低患冠心病的风险。世界各地的药物化学家一直在设计、合成和评估各种用于降低血脂水平的新型生物活性分子。本综述总结了与血液中脂质升高相关的疾病以及当前控制这些疾病的策略。特别强调了新的潜在生物学靶点、可能的治疗方法以及降脂药物领域当前的研究现状。